R 626 (Zafirlukast 20 mg)
Pill imprint R 626 has been identified as Zafirlukast 20 mg.
Zafirlukast is used in the treatment of asthma, maintenance and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Zafirlukast 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
- R 626
- 20 mg
- Prescription only
- Drug Class:
- Leukotriene modifiers
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- hydroxypropyl cellulose
hypromellose 2910 (5 mPa.s)
polyethylene glycol 400
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|68084-0059||Amerisource Health Services|
Note: Inactive ingredients may vary.
More about zafirlukast
- Other brands: Accolate
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.